Trinity Biotech (TRIB) Reports In-Line Q3 EPS

Trinity Biotech (NASDAQ: TRIB) reported Q3 EPS of $0.07, in-line with the analyst estimate of $0.07. Revenue for the quarter came in at $26.1 million versus the consensus estimate of $26.5 million.

For earnings history and earnings-related data on Trinity Biotech (TRIB) click here.

You May Also Be Interested In

• BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
• Costco Wholesale (COST) PT Raised to $1,040 at DA Davidson Following Q4 Earnings
• BofA says investors are increasingly worried about an AI boom-bust cycle